Disease Mongering of Age‐Associated Declines in Testosterone and Growth Hormone Levels

@article{Perls2015DiseaseMO,
  title={Disease Mongering of Age‐Associated Declines in Testosterone and Growth Hormone Levels},
  author={Thomas T. Perls and David J. Handelsman},
  journal={Journal of the American Geriatrics Society},
  year={2015},
  volume={63}
}
A combination of direct-to-consumer product advertising (DTCPA) and lax consensus guidelines for testosterone prescribing have, over the past decade, led to 10and 40-fold increases in testosterone prescriptions in the United States and Canada, respectively, with Internet pharmacies playing a major role in the latter’s increase. U.S. pharmaceutical sales of testosterone increased from $324 million in 2002 to $2 billion in 2012, and the number of testosterone doses prescribed climbed from 100… Expand

Topics from this paper

The Rise and Fall of Estrogen Therapy: Is Testosterone for "Manopause" Next?
TLDR
After the effects of estrogen-replacement therapy on postmenopausal women were studied and reported, the number of clinical prescriptions declined precipitously, which might herald a warning for men who pursue testosterone therapy to treat their age-related low testosterone levels. Expand
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
TLDR
Outcomes in many of these studies indicate that T therapy in the physiological range in hypogonadal men is a safe and effective therapeutic modality improving overall health and quality of life, however, such positive outcomes of T therapy on men’s health must be viewed with caution since long-term risks have yet to be identified. Expand
The marketing of testosterone treatments for age-related low testosterone or ‘Low T’
  • B. Mintzes
  • Medicine
  • Current opinion in endocrinology, diabetes, and obesity
  • 2018
TLDR
The review of the experience of promotion of testosterone for ‘Low T’ and research evidence on effects of advertising targeting the public highlights the need for improved regulation of unbranded ‘disease awareness’ advertising to ensure adequate protection of public. Expand
Trends in Testosterone Replacement Therapy Use from 2003 to 2013 among Reproductive‐Age Men in the United States
TLDR
In 2003 to 2013, testosterone replacement therapy use increased fourfold in men 18 to 45 years old compared to threefold in older men, and this younger age group should be a focus for future studies due to effects on fertility and unknown long‐term sequelae. Expand
A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
TLDR
The restrictions in subsidized TRT eligibility enforced by the PBS have reduced overall TRT prescriptions and slowed the cumulative financial burden. Expand
Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?
  • A. Traish
  • Medicine
  • American journal of physiology. Regulatory, integrative and comparative physiology
  • 2016
TLDR
A thorough and critical analysis of studies suggested that T therapy is associated with increased cardiovascular (CV) risk showed that the risks purported are unsubstantiated and such studies lacked credible scientific and clinical evidence. Expand
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
  • A. Traish
  • Medicine
  • Investigative and clinical urology
  • 2016
TLDR
There is considerable scientific and clinical evidence to suggest that testosterone therapy is safe and effective with restoration of physiological levels in men with testosterone deficiency, irrespective of its etiology. Expand
‘Forever Young’†—Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises
TLDR
Commercial mechanisms have laid the foundation for disease mongering of LOH and also have resulted a considerable expansion of the indications for treatment, which deserves particular attention since it is applicable to any drug with a purportedly favourable risk-benefit ratio not supported by evidence. Expand
Testosterone and Male Aging: Faltering Hope for Rejuvenation.
TLDR
Today, 8 decades since the first clinical use of testosterone, the sole unequivocal indication for testosterone treatment is as replacement therapy for men with pathological hypogonadism (ie, organic disorders of the reproductive system), yet despite no proven new indications, global testosterone sales increased 100-fold over the last 3 decades. Expand
Testosterone prescribing in men with depression and anxiety disorders.
TLDR
In men with depression and anxiety, TRT prescribing increased significantly from 2002 to 2013 and decreased from 2013 to 2016, and a significant proportion of men were prescribed TRT without a prior laboratory test for testosterone levels. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 28 REFERENCES
Testosterone up. A case of disease mongering?
TLDR
In this issue, changes in the patterns of testosterone prescribing in Australia from 1992 to 2010 are described and the concept of disease mongering is raised, which was described two decades ago. Expand
Lowered testosterone in male obesity: mechanisms, morbidity and management
TLDR
Whether testosterone therapy augments diet- and exercise-induced weight loss requires evaluation in adequately designed randomized controlled clinical trials. Expand
Is men's health just a single letter?
  • B. Anawalt
  • Medicine
  • The Journal of clinical endocrinology and metabolism
  • 2014
TLDR
Three recent epidemiological studies have fueled the debate on the effects of T on all-cause mortality and cardiovascular disease and suggest that there is a U-shaped association between serum total or calculated free serum T levels and all- Cause mortality, with a similar trend between T Levels and cardiovascular mortality. Expand
Testosterone and aging : clinical research directions
TLDR
The risks and benefits of testosterone replacement therapy, the potential public health impact of such therapy in the United States, and the potential ethical issues related to the conduct of clinical trials are examined. Expand
New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding.
TLDR
Clinical evidence does support the therapeutic administration of hGH for children and adults with appropriate clinical indications, but extrapolating from this evidence to conclude that hGH improves health or longevity in normally aging individuals is not justified. Expand
Disease mongering and low testosterone in men: the tale of two regulatory failures
TLDR
Disease-awareness campaigns on low testosterone and ageing highlight the need for changes to regulations and there are many examples of drug company-funded disease- awareness campaigns that exaggerate disease risks and prevalence. Expand
Comparison of screening questionnaires for the diagnosis of hypogonadism.
TLDR
The ADAM and AMS may be useful screening tools for hypogonadism across the adult lifespan, but both are relatively nonspecific. Expand
Identification of late-onset hypogonadism in middle-aged and elderly men.
TLDR
Symptoms of poor morning erection, low sexual desire, erectile dysfunction, inability to perform vigorous activity, depression, and fatigue were significantly related to the testosterone level, and an inverse relationship between an increasing number of sexual symptoms and a decreasing testosterone level was observed. Expand
Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.
TLDR
Data highlight the association between pelvic fracture and genitourinary injuries in survivors of wartime combat, and suggest that a multidisciplinary approach be used to diagnose and treat these wounded veterans. Expand
Selling sickness: the pharmaceutical industry and disease mongering.
TLDR
Some forms of medicalising ordinary life may now be better described as disease mongering: widening the boundaries of treatable illness in order to expand markets for those who sell and deliver treatments. Expand
...
1
2
3
...